Franklin Genomic Etf Forecast - Naive Prediction
| HELX Etf | USD 29.53 0.29 0.99% |
The Naive Prediction forecasted value of Franklin Genomic Advancements on the next trading day is expected to be 28.42 with a mean absolute deviation of 0.45 and the sum of the absolute errors of 28.11. Franklin Etf Forecast is based on your current time horizon.
Franklin |
Franklin Genomic Naive Prediction Price Forecast For the 23rd of November
Given 90 days horizon, the Naive Prediction forecasted value of Franklin Genomic Advancements on the next trading day is expected to be 28.42 with a mean absolute deviation of 0.45, mean absolute percentage error of 0.29, and the sum of the absolute errors of 28.11.Please note that although there have been many attempts to predict Franklin Etf prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Franklin Genomic's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Franklin Genomic Etf Forecast Pattern
| Backtest Franklin Genomic | Franklin Genomic Price Prediction | Buy or Sell Advice |
Franklin Genomic Forecasted Value
In the context of forecasting Franklin Genomic's Etf value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Franklin Genomic's downside and upside margins for the forecasting period are 27.21 and 29.63, respectively. We have considered Franklin Genomic's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Franklin Genomic etf data series using in forecasting. Note that when a statistical model is used to represent Franklin Genomic etf, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 118.6962 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.4533 |
| MAPE | Mean absolute percentage error | 0.0145 |
| SAE | Sum of the absolute errors | 28.1053 |
Predictive Modules for Franklin Genomic
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Franklin Genomic Adv. Regardless of method or technology, however, to accurately forecast the etf market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the etf market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Other Forecasting Options for Franklin Genomic
For every potential investor in Franklin, whether a beginner or expert, Franklin Genomic's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Franklin Etf price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Franklin. Basic forecasting techniques help filter out the noise by identifying Franklin Genomic's price trends.Franklin Genomic Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Franklin Genomic etf to make a market-neutral strategy. Peer analysis of Franklin Genomic could also be used in its relative valuation, which is a method of valuing Franklin Genomic by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Franklin Genomic Adv Technical and Predictive Analytics
The etf market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Franklin Genomic's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Franklin Genomic's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Franklin Genomic Market Strength Events
Market strength indicators help investors to evaluate how Franklin Genomic etf reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Franklin Genomic shares will generate the highest return on investment. By undertsting and applying Franklin Genomic etf market strength indicators, traders can identify Franklin Genomic Advancements entry and exit signals to maximize returns.
Franklin Genomic Risk Indicators
The analysis of Franklin Genomic's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Franklin Genomic's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting franklin etf prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 0.8691 | |||
| Standard Deviation | 1.19 | |||
| Variance | 1.42 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Franklin Genomic Adv offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Franklin Genomic's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Franklin Genomic Advancements Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Franklin Genomic Advancements Etf:Check out Historical Fundamental Analysis of Franklin Genomic to cross-verify your projections. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
The market value of Franklin Genomic Adv is measured differently than its book value, which is the value of Franklin that is recorded on the company's balance sheet. Investors also form their own opinion of Franklin Genomic's value that differs from its market value or its book value, called intrinsic value, which is Franklin Genomic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Franklin Genomic's market value can be influenced by many factors that don't directly affect Franklin Genomic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Franklin Genomic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Franklin Genomic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Franklin Genomic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.